The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma

Renal cell carcinoma (RCC) is the sixth most common cancer in the US. However, no significant changes in management have occurred since the tyrosine kinase era until the recent breakthrough with checkpoint inhibitors. Therefore, the need for more therapeutic options is paramount. Our objective was t...

Full description

Saved in:
Bibliographic Details
Published in:Front Oncol
Main Authors: Pletcher, Jerred P., Bhattacharjee, Sayani, Doan, Jonathan P., Wynn, Rebecca, Sindhwani, Puneet, Nadiminty, Nagalakshmi, Petros, Firas G.
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2021
Subjects:
Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8300201/
https://ncbi.nlm.nih.gov/pubmed/34307148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.681441
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items